Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

NCT04138758 · clinicaltrials.gov ↗

COMPLETED

Status

42953

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Tiotropium bromide + Olodaterol
DRUG: LABA/ICS

Sponsor

Boehringer Ingelheim